ArticleScientific reports2018

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.

Matthieu Chodorge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.